NCT06550427
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +20 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan
Clinical trial condition
Waldenstrom Macroglobulinemia
Explore clinical trials studying Waldenstrom Macroglobulinemia. Study availability and eligibility vary by location and protocol.
397 public trials
44 recruiting studies
Waldenstrom Macroglobulinemia trial results
NCT04898647
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- CHU Amiens Amiens, France
NCT05914662
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China
NCT04061512
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Royal United Hospital, Bath Bath, United Kingdom
- The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust Bournemouth, United Kingdom
- East Kent Hospitals University NHS Foundation Trust Canterbury, United Kingdom
- University Hospital of Wales Cardiff, United Kingdom
Not yet recruiting
Mosunetuzumab in Combination With Pirtobrutinib in Patients With Relapsed or Refractory Waldenstrom Macroglobulinemia (MPOWER)
NCT07548450
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Huntsman Cancer Institute at University of Utah Salt Lake City, Utah, United States
Not yet recruiting
Teclistamab In Waldenstrom's Macroglobulinemia
NCT07791498
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +18 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Not yet recruiting
Evaluation of Iopofosine I 131 vs. R-CD in WM Patients
NCT07766421
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
- Locations
-
Not specified
Not yet recruiting
Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy
NCT07711327
- Conditions
- Arrhythmias, Cardiac, Atrial Fibrillation, Atrial Fibrillation (AF), +35 more
- Locations
-
- City of Hope Duarte, California, United States
- UC San Diego Health San Diego, California, United States
- Stanford Health Care Stanford, California, United States
NCT07420959
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Not yet recruiting
Connected Blood Pressure Monitoring in Patients With Hematologic Malignancies Initiating Covalent BTK Inhibitors
NCT07592481
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +34 more
- Locations
-
Not specified